SCYNEXIS (SCYX) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 25, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 24, 2026.

Voting matters and shareholder proposals

• Election of six nominees to the Board of Directors to serve until the 2027 Annual Meeting.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes.

• Approval of amendment to the 2024 Equity Incentive Plan to increase authorized shares by 9,600,000.

• Approval of amendment to Certificate of Incorporation to increase authorized common stock to 60,000,000 or 300,000,000 shares, depending on reverse stock split outcome.

Board of directors and corporate governance

• Six director nominees listed: Armando Anido, David Angulo, Ann F. Hanham, David Hastings, Guy Macdonald, and Philippe Tinmouth.